Compositions and methods for producing bioactive fusion proteins

Details for Australian Patent Application No. 2011213759 (hide)

Owner Amgen Inc.

Inventors Walker, Kenneth W.; Gegg Jr., Colin V.

Agent Shelston IP

Pub. Number AU-B-2011213759

Parent 2008262490

Filing date 18 August 2011

Wipo publication date 8 September 2011

Acceptance publication date 7 June 2012

International Classifications

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

Event Publications

8 September 2011 Application Open to Public Inspection

  Published as AU-B-2011213759

8 September 2011 Complete Application Filed

7 June 2012 Application Accepted

  Published as AU-B-2011213759

4 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011213760-Compositions and methods for producing bioactive fusion proteins

2011213758-Identification of cancer protein biomarkers using proteomic techniques